QUICK LINKS
MAIN MENU
CONNECT WITH US

Button

Clinical Trial Details

Title
A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects with Nonalcoholic Steatohepatitis
Study Description

The purpose of this study is to find out if OCA may be safe and effective in delaying specific medical conditions or health related issues that can occur in patients with NASH and evidence of liver fibrosis.

Subjects will be randomized to 1 of 2 study drug doses or placebo.

Investigators

Principal Investigator
Maged P. Ghali, M.D.
Medicine

Principal Investigator
James S. Scolapio, M.D.
Medicine

Resources

News & Announcements

Upcoming Events

Apr 14